Compound Detail
CHEMBL3770459
LENRISPODUN PHOSPHATE Phase I
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
Phase I
CN1C(=O)c2c(nn(Cc3ccc(-c4cccc(F)n4)cc3)c2Nc2ccccc2)N2C1=N[C@@H]1CCC[C@@H]12.O=P(O)(O)O
Basic Information
| ChEMBL ID | CHEMBL3770459 |
| Name | LENRISPODUN PHOSPHATE |
| Phase | Phase I |
| Structure Type | MOL |
| InChI Key | ZPIAAFIYOPWWJL-RFPXDPOKSA-N |
| Parent Compound | CHEMBL3769414 |
| Active Moiety | CHEMBL3769414 |
12
Targets
23
Activities
2
Assay Types
14
PK Parameters
20
Publications
8
Known Names
3
Indications
Molecular Properties
507.6
MW (Da)
5.06
ALogP
7
HBA
1
HBD
78.7
PSA (Ų)
0.38
QED
2
Ro5 Violations
5
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| Chirality | Single Enantiomer |
Indications
Cardiovascular Diseases Nervous System Diseases Parkinson Disease
Activity Summary
Ki 22 meas. best 10.24
IC50 1 meas. best 10.24
Target Activity Profile
Pharmacokinetic Data
| Parameter | Value | Units | Species |
|---|---|---|---|
| AUC | 826.0 | ng.hr.mL-1 | Mus musculus |
| AUC | 588.0 | ng.hr.mL-1 | Mus musculus |
| AUC | 300.0 | ng.hr.mL-1 | Rattus norvegicus |
| AUC | 802.0 | ng.hr.mL-1 | Rattus norvegicus |
| CL | 78.0 | mL.min-1.kg-1 | Homo sapiens |
| CL | 55.0 | mL.min-1.kg-1 | Rattus norvegicus |
| Cmax | 965.38 | nM | Mus musculus |
| Cmax | 762.46 | nM | Mus musculus |
| Cmax | 496.48 | nM | Rattus norvegicus |
| F | 28.0 | % | Rattus norvegicus |
| T1/2 | 1.4 | hr | Rattus norvegicus |
| T1/2 | 1.5 | hr | Rattus norvegicus |
| Tmax | 0.75 | hr | Rattus norvegicus |
| Vd | 6.83 | L.kg-1 | Rattus norvegicus |
Activity Data Samples
Top measurements by pChEMBL value
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 26789933 | 10.1021/acs.jmedchem.5b01751 | Rattus norvegicus | 10 |
| - | 10.6019/CHEMBL5303304 | HEK-293T | 5 |
| - | 10.6019/CHEMBL5303304 | U2OS | 5 |
| - | 10.6019/CHEMBL5303304 | Fibroblast | 5 |
| 26789933 | 10.1021/acs.jmedchem.5b01751 | Unchecked | 3 |
| 26789933 | 10.1021/acs.jmedchem.5b01751 | No relevant target | 3 |
| - | 10.6019/CHEMBL4495565 | SARS-CoV-2 | 2 |
| 38000211 | 10.1016/j.ejmech.2023.115967 | Unchecked | 2 |
| 26789933 | 10.1021/acs.jmedchem.5b01751 | Brain | 2 |
| 26789933 | 10.1021/acs.jmedchem.5b01751 | Plasma | 2 |
| 26789933 | 10.1021/acs.jmedchem.5b01751 | Dual 3',5'-cyclic-AMP and -GMP phosphodiesterase 11A | 1 |
| - | 10.21203/rs.3.rs-23951/v1 | SARS-CoV-2 | 1 |
| 38000211 | 10.1016/j.ejmech.2023.115967 | Dual 3',5'-cyclic-AMP and -GMP phosphodiesterase 11A | 1 |
| 26789933 | 10.1021/acs.jmedchem.5b01751 | cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A | 1 |
| 26789933 | 10.1021/acs.jmedchem.5b01751 | High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A | 1 |
| 26789933 | 10.1021/acs.jmedchem.5b01751 | High affinity cAMP-specific and IBMX-insensitive 3',5'-cyclic phosphodiesterase 8A | 1 |
| 26789933 | 10.1021/acs.jmedchem.5b01751 | cGMP-specific 3',5'-cyclic phosphodiesterase | 1 |
| 26789933 | 10.1021/acs.jmedchem.5b01751 | cGMP-inhibited 3',5'-cyclic phosphodiesterase 3B | 1 |
| 26789933 | 10.1021/acs.jmedchem.5b01751 | cGMP-dependent 3',5'-cyclic phosphodiesterase | 1 |
| 26789933 | 10.1021/acs.jmedchem.5b01751 | Liver microsome | 1 |
Data from ChEMBL 36 via Core Engine